News
BIO
317.69
-0.74%
-2.37
A Look at Bio-Rad Laboratories’s Valuation Following New StarBright Dye Launch for Flow Cytometry
Simply Wall St · 6d ago
Weekly Report: what happened at BIO last week (1124-1128)?
Weekly Report · 6d ago
Does Bio-Rad’s Expanded StarBright Dye Line Shift the Innovation Narrative for BIO?
Simply Wall St · 11/29 21:22
3 Stocks Flashing ‘Buy’ Alerts for Investors on Technical Charts
TipRanks · 11/25 13:47
Weekly Report: what happened at BIO last week (1117-1121)?
Weekly Report · 11/24 09:41
Weekly Report: what happened at BIO last week (1110-1114)?
Weekly Report · 11/17 09:42
Is Bio-Rad’s Third Quarter Net Loss and Share Buyback Shaping the Investment Case for BIO?
Simply Wall St · 11/12 07:22
Bio-Rad Laboratories (BIO): Assessing Valuation Following Q3 Loss and Share Buyback Completion
Simply Wall St · 11/11 02:24
Top Executive Sells Bio-Rad Laboratories Stock in Major Transaction
TipRanks · 11/11 02:13
Goldman says healthcare is ripe for stock picking; here's some they like
Seeking Alpha · 11/10 16:19
Weekly Report: what happened at BIO last week (1103-1107)?
Weekly Report · 11/10 09:40
Weekly Report: what happened at BIO last week (1027-1031)?
Weekly Report · 11/03 09:39
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships?
Simply Wall St · 11/02 22:27
Assessing Bio-Rad Laboratories’s Valuation After Posting a Sharp Quarterly Net Loss Despite Stable Sales
Simply Wall St · 11/01 20:41
Bio-Rad Laboratories’ Earnings Call Highlights Resilience
TipRanks · 10/31 00:08
Bio-Rad Laboratories (BIO): Losses Widen 51% Annually, Undervalued Status Reinforces Turnaround Narrative
Simply Wall St · 10/30 22:34
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday
The Motley Fool · 10/30 21:17
Bio-Rad Laboratories Price Target Raised to $375.00/Share From $350.00 by Citigroup
Dow Jones · 10/30 18:33
Bio-Rad Laboratories Is Maintained at Buy by Citigroup
Dow Jones · 10/30 18:33
Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $375
Benzinga · 10/30 18:23
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.